Spun out of the University of North Carolina (UNC), the start-up's approach enables it to incorporate therapeutic agents inside the particle in any concentration, or even use them to mold the particle itself.

FORBES: Nanotech Puts Cancer In The Cross Hairs

Based on a careful review of applications for novel therapeutic agents approved from 2001 through 2010, we found that the FDA was almost two months faster than the European Medicines Agency and Health Canada.

FORBES: The FDA Is Faster. Now Let's Make It Safer

That is prudent since stem cells are potentially powerful agents with little therapeutic history.

FORBES